For instance, Jentzsch et al. described a low relapse rate and favorable outcomes of older NPM1MT/FLT3-ITDNEG AML patients consolidated with allogeneic stem cell transplant in CR1 [39]. Here, FLT3 is linked to acute myeloid leukemia.